Jaguar Health, Inc.

NasdaqCM:JAGX Stock Report

Market Cap: US$10.9m

Jaguar Health Management

Management criteria checks 4/4

Jaguar Health's CEO is Lisa Conte, appointed in Jun 2013, has a tenure of 11.5 years. total yearly compensation is $815.85K, comprised of 70.6% salary and 29.4% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $15.39K. The average tenure of the management team and the board of directors is 4 years and 6.8 years respectively.

Key information

Lisa Conte

Chief executive officer

US$815.9k

Total compensation

CEO salary percentage70.6%
CEO tenure11.5yrs
CEO ownership0.1%
Management average tenure4yrs
Board average tenure6.8yrs

Recent management updates

Recent updates

Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 27%

Nov 09
Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 27%

Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 27%

Nov 09
Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 27%

Jaguar Health, Inc. (NASDAQ:JAGX) Stock's 55% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 24
Jaguar Health, Inc. (NASDAQ:JAGX) Stock's 55% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 49%

May 24
Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 49%

Jaguar Health, Inc. (NASDAQ:JAGX) Shares Fly 55% But Investors Aren't Buying For Growth

Mar 29
Jaguar Health, Inc. (NASDAQ:JAGX) Shares Fly 55% But Investors Aren't Buying For Growth

Jaguar Health, Inc. (NASDAQ:JAGX) Not Doing Enough For Some Investors As Its Shares Slump 39%

Jan 22
Jaguar Health, Inc. (NASDAQ:JAGX) Not Doing Enough For Some Investors As Its Shares Slump 39%

Positive Sentiment Still Eludes Jaguar Health, Inc. (NASDAQ:JAGX) Following 32% Share Price Slump

Jun 10
Positive Sentiment Still Eludes Jaguar Health, Inc. (NASDAQ:JAGX) Following 32% Share Price Slump

Jaguar Health (NASDAQ:JAGX) Is Carrying A Fair Bit Of Debt

Jan 23
Jaguar Health (NASDAQ:JAGX) Is Carrying A Fair Bit Of Debt

Jaguar Health rises 19% on orphan drug tag for congenital diarrheal disorder treatment

Oct 17

Jaguar Health sells crofelemer and lechlemer royalty rights for $4M upfront

Aug 25

Jaguar Health gets 180-day grace period to regain compliance with Nasdaq's listing rule

Aug 19

Jaguar Health rises on U.S. patent for treating chemotherapy-induced diarrhea

Aug 09

Jaguar stock rises on license deal with SynWorld for Canalevia in China

Jun 29

Jaguar Health CEO Lisa Conte - From Rainforest To Laboratory

Mar 07

Jaguar Health shares jumps 13% after pricing $15M direct offering

Jan 13

Jaguar Health plans for conditional marketing application in Europe for Crofelemer, initially for Long-Hauler COVID-19 patients

Jan 11

Jaguar Health leaps higher in new year

Jan 05

Jaguar Health inks second Mytesi royalties agreement for $6M

Dec 23

Does Jaguar Health (NASDAQ:JAGX) Have A Healthy Balance Sheet?

Dec 02
Does Jaguar Health (NASDAQ:JAGX) Have A Healthy Balance Sheet?

Jaguar Health's crofelemer development nears SPAC funding in Europe, shares +61%

Nov 30

Jaguar Health EPS misses by $0.10, misses on revenue

Nov 16

Jaguar Health receives positive Nasdaq listing determination

Oct 29

CEO Compensation Analysis

How has Lisa Conte's remuneration changed compared to Jaguar Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$38m

Jun 30 2024n/an/a

-US$36m

Mar 31 2024n/an/a

-US$38m

Dec 31 2023US$816kUS$576k

-US$41m

Sep 30 2023n/an/a

-US$40m

Jun 30 2023n/an/a

-US$44m

Mar 31 2023n/an/a

-US$42m

Dec 31 2022US$1mUS$603k

-US$47m

Sep 30 2022n/an/a

-US$54m

Jun 30 2022n/an/a

-US$54m

Mar 31 2022n/an/a

-US$59m

Dec 31 2021US$3mUS$527k

-US$53m

Sep 30 2021n/an/a

-US$50m

Jun 30 2021n/an/a

-US$46m

Mar 31 2021n/an/a

-US$42m

Dec 31 2020US$1mUS$500k

-US$39m

Sep 30 2020n/an/a

-US$35m

Jun 30 2020n/an/a

-US$39m

Mar 31 2020n/an/a

-US$45m

Dec 31 2019US$1mUS$500k

-US$45m

Sep 30 2019n/an/a

-US$48m

Jun 30 2019n/an/a

-US$43m

Mar 31 2019n/an/a

-US$34m

Dec 31 2018US$1mUS$480k

-US$32m

Sep 30 2018n/an/a

-US$41m

Jun 30 2018n/an/a

-US$30m

Mar 31 2018n/an/a

-US$24m

Dec 31 2017US$643kUS$440k

-US$22m

Compensation vs Market: Lisa's total compensation ($USD815.85K) is about average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Lisa's compensation has been consistent with company performance over the past year.

CEO

Lisa Conte (65 yo)

11.5yrs

Tenure

US$815,854

Compensation

Ms. Lisa A. Conte serves as a Scientific Advisor at Triton Funds LLC. She is a Former Member of Scientific Advisory Board at Triton Funds LLC. She founded Jaguar Health, Inc. (formerly known as Jaguar Anim...

Leadership Team

NamePositionTenureCompensationOwnership
Lisa Conte
Founder11.5yrsUS$815.85k0.14%
$ 15.4k
Pravin Chaturvedi
Chief Scientific Officer & Chair of Scientific Advisory Board2.8yrsUS$627.13k0.042%
$ 4.6k
Jonathan Wolin
Chief of Staff6.1yrsUS$562.79k0.042%
$ 4.6k
Steven King
Chief of Sustainable Supply10.3yrsUS$491.54k0.042%
$ 4.6k
Carol Lizak
Chief Financial Officer4.8yrsno data0.036%
$ 4.0k
Peter Hodge
Senior Director of Investor Relationsno datano datano data
Karen Brunke
Executive VP of Corporate & Business Development3.3yrsno datano data
David Sesin
Chief Manufacturing Officerno datano datano data
Ian Wendt
Chief Commercial Officer4yrsUS$557.90kno data
Massimo Radaelli
President of Jaguar Internationalless than a yearno datano data
Catherine Collis
Senior Vice President of Growth Strategyless than a yearno datano data
Darlene Horton
Chief Medical Officerno datano datano data

4.0yrs

Average Tenure

62yo

Average Age

Experienced Management: JAGX's management team is considered experienced (4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lisa Conte
Founder11.5yrsUS$815.85k0.14%
$ 15.4k
Pravin Chaturvedi
Chief Scientific Officer & Chair of Scientific Advisory Board7.6yrsUS$627.13k0.042%
$ 4.6k
James Bochnowski
Independent Chairman10.8yrsUS$140.98k0.00032%
$ 34.9
John Micek
Independent Director8.7yrsUS$101.68k0.00019%
$ 20.7
Anula Jayasuriya
Independent Director2.4yrsUS$77.61k0.00025%
$ 27.3
Jonathan Siegel
Independent Director6.8yrsUS$104.18k0.00020%
$ 21.8
Sandra Swain
Member of Scientific Advisory Board1.9yrsno datano data
Kelly Shanahan
Scientific Advisory Board1.8yrsno datano data
Stacey Tinianov
Member of Scientific Advisory Board1.6yrsno datano data

6.8yrs

Average Tenure

67yo

Average Age

Experienced Board: JAGX's board of directors are considered experienced (6.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:12
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jaguar Health, Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert LeBoyerAegis Capital Corporation
Louise ChenCantor Fitzgerald & Co.
Vernon BernardinoH.C. Wainwright & Co.